Breaking GroundDecoding DemocracyI've Always Wondered ...Baltimore Bridge Collapse

Loading...

0:00
0% played
🌎 It’s World Press Freedom Day. Stand with Marketplace and our independent journalism. Donate now
Stories Tagged as

COVID-19

Job hunting in China's slowing economy

by Jennifer Pak
Aug 15, 2022
The unemployment rate is high among young Chinese graduates. What does it take a get a job in such a tough economy?
A busy Shanghai job fair in 2018. Since then, unemployment among 16- to 24-year-olds has steadily climbed, reaching 19.9% last month.
Charles Zhang/Marketplace
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Between COVID and pent-up vacation demand, absent workers have businesses scrambling

by Kristin Schwab
Jul 27, 2022
Hire more workers or do less business — the options aren't great.
Employers across industries are getting creative as more workers take time off.
Ed Jones/AFP via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Pandemic darlings try to get past "the party's over"

by Kristin Schwab
Jul 20, 2022
Peloton, Netflix and others have to predict how their customers will behave. But amid pandemic disruption, it's an uphill battle.
Business has declined at some companies that flourished during COVID-19 lockdowns, like Netflix.
Chris Delmas/AFP via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE
COVID-19

Shanghai's lockdown has eased, but businesses are still tallying the costs

by Jennifer Pak
Jul 14, 2022
Shanghai's lockdown crippled supply chains and logistics. Materials and transport costs climbed, and there have been personal struggles too.
Authorities put barriers around Shanghai streets to enforce the severe lockdown in the spring.
Charles Zhang/Marketplace
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE
COVID-19

Health professionals wonder about future of COVID drugs as federal funding wanes

by Lily Jamali
Jun 29, 2022
Drugmaker Eli Lilly will supply the government with another 150,000 doses of its monoclonal antibody to meet short-term demand.
A free monoclonal antibody treatment site in Miami. Eli Lilly said it will provide more of its antibody medication to the government, but drugmakers may shift their sales to the commercial market.
Joe Raedle/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Work at the office, work from home or both? Companies are still deciding what's best.

by Kristin Schwab
Jun 24, 2022
The purpose of the workplace is changing for businesses that let employees work both remotely and in the office.
Businesses are still trying to find a balance between employees working both remotely and in the office.
Petras Malukas/AFP via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE
COVID-19

Corporations' decisions seem to signal the end of the pandemic

by Kristin Schwab
Jun 22, 2022
“Some companies are large enough that they can be the trendsetters,” one health economist tells us.
Broadway, which has been stringent on COVID-19 restrictions, is lifting its mask mandate on July 1.
Spencer Platt/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

For public good, not for profit.

Donate
COVID-19

For kids who lost parents to COVID, the financial consequences compound the emotional toll

by Alisa Roth
Jun 9, 2022
Losing a parent can have long-term financial implications for children.
Aidan (left), and Julius Garza (center), lost their father, David (right), to COVID-19 almost two years ago.
Courtesy Margaret Garza
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE
COVID-19

At this point in the pandemic, will there be a market for the Novavax vaccine?

by Kristin Schwab
Jun 8, 2022
The anti-COVID shot passes muster with FDA advisers. It was developed with traditional technology, which might boost trust.
Experts recommended that the FDA approve Novavax's new COVID vaccine, which was created with more traditional technology than the methods used by Pfizer and Moderna.
Carsten Koall/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Retailers have an inventory problem as lockdown lifestyle fades

by Savannah Maher
Jun 7, 2022
As inflation hits and consumers abandon pandemic spending habits, Target and others have the wrong kind of stuff on their hands.
The home goods section at a Target store. Now that consumers are getting out and about, stores are left with too much inventory.
Joe Raedle/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE